• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Risk for post-injection syndrome after administration of olanzapine depot : Findings of real-world data evaluation at a psychiatric university hospital with a full-range care mandate].

作者信息

Strube Wolfgang, Wagner Elias, Gartenmaier Andreas, Grünemeyer Antje, Schmelzer Klaus Peter, Hasan Alkomiet

机构信息

Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Medizinische Fakultät, Universität Augsburg, 86156, Augsburg, Deutschland.

Evidenzbasierte Psychiatrie und Psychotherapie, Medizinische Fakultät, Universität Augsburg, Stenglinstraße 2, 86156, Augsburg, Deutschland.

出版信息

Nervenarzt. 2025 May;96(3):290-293. doi: 10.1007/s00115-024-01733-2. Epub 2024 Sep 17.

DOI:10.1007/s00115-024-01733-2
PMID:39287812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12058942/
Abstract
摘要

相似文献

1
[Risk for post-injection syndrome after administration of olanzapine depot : Findings of real-world data evaluation at a psychiatric university hospital with a full-range care mandate].奥氮平长效注射剂给药后发生注射后综合征的风险：一家负有全方位护理使命的精神科大学医院的真实世界数据评估结果
Nervenarzt. 2025 May;96(3):290-293. doi: 10.1007/s00115-024-01733-2. Epub 2024 Sep 17.
2
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].[精神分裂症患者护理环境的成本效益分析：长效注射制剂下非典型抗精神病药物的影响]
Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5.
3
[Post-injection syndrome after depot injection of olanzapine].[奥氮平长效注射剂注射后综合征]
Ned Tijdschr Geneeskd. 2014;159:A7885.
4
Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study.接受奥氮平长效注射剂治疗的精神分裂症患者的基线特征和住院情况：一项非干预性前瞻性观察性安全性研究的中期分析
BMC Psychiatry. 2015 Nov 13;15:278. doi: 10.1186/s12888-015-0669-5.
5
Evaluation of olanzapine pamoate depot in seriously violent males with schizophrenia in the community.奥氮平棕榈酸酯长效注射剂用于社区中患有精神分裂症的严重暴力男性的评估。
Ther Adv Psychopharmacol. 2016 Oct;6(5):301-307. doi: 10.1177/2045125316656319. Epub 2016 Aug 8.
6
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.给编辑的信：重新思考抗精神病药物治疗的成本：2020 年土耳其使用的药物的平均成本。
Turk Psikiyatri Derg. 2022 Summer;33(2):146-148. doi: 10.5080/u26315.
7
D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophrenia.使用正电子发射断层扫描术评估奥氮平帕莫酸盐长效注射剂的D2受体占有率：一项针对精神分裂症患者的开放标签研究。
Neuropsychopharmacology. 2008 Jan;33(2):298-304. doi: 10.1038/sj.npp.1301409. Epub 2007 Apr 18.
8
Switching from depot antipsychotic drugs to olanzapine in patients with chronic schizophrenia.慢性精神分裂症患者从长效抗精神病药物换用奥氮平的情况
J Clin Psychiatry. 2003 Feb;64(2):119-22. doi: 10.4088/jcp.v64n0203.
9
Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study.奥氮平长效注射剂维持治疗 6 个月期间精神病住院的预测因素：一项随机、双盲研究的事后分析。
BMC Psychiatry. 2013 Sep 16;13:224. doi: 10.1186/1471-244X-13-224.
10
Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism.奥氮平长效注射剂治疗精神分裂症患者的注射后谵妄/镇静综合征，II：机制研究。
BMC Psychiatry. 2010 Jun 10;10:45. doi: 10.1186/1471-244X-10-45.

本文引用的文献

1
Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice.奥氮平长效注射剂：常规临床实践中注射后谵妄/镇静综合征首次经验的综述
BMC Psychiatry. 2015 Apr 2;15:65. doi: 10.1186/s12888-015-0450-9.
2
Post-injection delirium/sedation syndrome in patients treated with olanzapine pamoate: mechanism, incidence, and management.接受奥氮平棕榈酸酯治疗的患者出现注射后谵妄/镇静综合征：机制、发生率及处理
CNS Drugs. 2015 Jan;29(1):41-6. doi: 10.1007/s40263-014-0216-9.
3
Long-term safety and efficacy of olanzapine long-acting injection in patients with schizophrenia or schizoaffective disorder: a 6-year, multinational, single-arm, open-label study.奥氮平长效注射剂治疗精神分裂症或分裂情感性障碍患者的长期安全性和有效性：一项为期6年的多国单臂开放标签研究。
Int Clin Psychopharmacol. 2014 Nov;29(6):322-31. doi: 10.1097/YIC.0000000000000038.
4
Long-acting injectable antipsychotics and the development of postinjection delirium/sedation syndrome (PDSS).长效注射用抗精神病药物与注射后谵妄/镇静综合征（PDSS）的发生发展
Clin Neuropharmacol. 2013 Mar-Apr;36(2):59-62. doi: 10.1097/WNF.0b013e3182854f70.
5
Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases.奥氮平长效注射剂治疗精神分裂症患者的注射后谵妄/镇静综合征，I：病例分析。
BMC Psychiatry. 2010 Jun 10;10:43. doi: 10.1186/1471-244X-10-43.